Plain language
We translate complex material without turning uncertainty into certainty or reducing serious questions to a slogan.
Still Threshold 23
About
An independent resource on ibogaine, neuroplasticity, evidence, and safety—built to distinguish early biological findings from established clinical evidence in calm, clear language.
Why this exists
Careful context for consequential questions
Lacuna Flint is the independent resource behind Still Threshold 23. It exists for adults seeking accessible context about ibogaine and related safety questions without presenting itself as a clinic, provider, or treatment center.
Evidence context
We separate laboratory observations, early human signals, and conclusions that require stronger clinical support.
Safety clarity
We make room for limits, risks, and the difference between information and individualized medical guidance.
Our editorial approach
Sources before certainty
Our work is organized around clear questions, careful definitions, and source-aware explanations. We consult research literature, study registries, and official materials, then describe what they can—and cannot—reasonably support.
For example, clinical-trial records are available through the official ClinicalTrials.gov registry, while broader research literacy benefits from understanding how the scientific method tests and revises claims over time.
Visitors who want the topic framing that prompted this resource can return to our careful evidence overview; those looking for a plain-language map of the site’s practical information can review our resource pathways.
What guides the work
Independence means showing the seams.
We aim to make the boundaries of a claim visible: where a source comes from, what kind of evidence it represents, and why a reader should be cautious about extending it beyond its setting.
- Scientific humility
- Safety clarity
- Plain language
- Evidence context
- Independence
What we cover
A map of questions, not a promise of answers
Still Threshold 23 gathers material on ibogaine, noribogaine, neuroplasticity, and related safety questions into distinct pathways so readers can tell background context from human evidence, mechanisms, and research priorities.
That organization also helps readers locate focused context when their questions touch on alcohol-related claims, PTSD treatment questions, or broader discussions of ibogaine and addiction. These links are informational starting points, not endorsements of services or treatment outcomes.
We also recognize that people may encounter location-based or provider-seeking pages such as Baja ibogaine treatment, a nearby ibogaine clinic, and ibogaine clinics in Mexico. Their presence does not change our role: this site does not evaluate, refer to, or operate treatment providers.
“Useful information is not a substitute for care, consent, screening, or clinical judgment.”
Who this is for
For adults looking for a steadier frame
This resource is for people who want to assess claims with more care, including those encountering discussions of ibogaine and 5-MeO-DMT or viewing an ibogaine documentary. It is also for readers who need clear reminders that a compelling story, a personal account, or an early finding is not the same as settled evidence.
When safety is part of the question, official public-health guidance remains important. The U.S. Food and Drug Administration explains its role in drug development and approval; it is a useful reference point for understanding why clinical claims require rigorous evaluation.
Independent by design
Information can be careful without pretending to be care.
Still Threshold 23 is an independent information resource. It does not provide medical or legal advice, diagnose conditions, recommend treatment, or act as a clinic, medical provider, or licensed treatment center.